FERNANDO ANTONIO
RODRÍGUEZ DE FONSECA
Catedrático de universidad
NURIA
GARCÍA MARCHENA
Profesora ayudante doctora
Publications dans lesquelles il/elle collabore avec NURIA GARCÍA MARCHENA (23)
2023
-
Antidepressant Medication Does Not Contribute to the Elevated Circulating Concentrations of Acylethanolamides Found in Substance Use Disorder Patients
International Journal of Molecular Sciences, Vol. 24, Núm. 19
-
Antipsychotic Medication Influences the Discriminative Value of Acylethanolamides as Biomarkers of Substance Use Disorder
International journal of molecular sciences, Vol. 24, Núm. 11
-
Associations of hypomagnesemia in patients seeking a first treatment of alcohol use disorder
Drug and Alcohol Dependence, Vol. 245
-
Plasma Concentrations of Neurofilament Light Chain Protein and Brain-Derived Neurotrophic Factor as Consistent Biomarkers of Cognitive Impairment in Alcohol Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 2
-
Plasma Lysophosphatidic Acid Concentrations in Sex Differences and Psychiatric Comorbidity in Patients with Cocaine Use Disorder
International Journal of Molecular Sciences, Vol. 24, Núm. 21
-
Plasma concentrations of lysophosphatidic acid and the expression of its receptors in peripheral blood mononuclear cells are altered in patients with cocaine use disorders
Translational Psychiatry, Vol. 13, Núm. 1
2022
-
Niveles plasmáticos de midkina en pacientes con trastorno por uso de cocaína en abstinencia
Adicciones: Revista de socidrogalcohol, Vol. 34, Núm. 4, pp. 273-277
-
Vascular Endothelial Growth Factor as a Potential Biomarker of Neuroinflammation and Frontal Cognitive Impairment in Patients with Alcohol Use Disorder
Biomedicines, Vol. 10, Núm. 5
2021
-
Evaluation of neurotrophic factors and education level as predictors of cognitive decline in alcohol use disorder
Scientific Reports, Vol. 11, Núm. 1
-
Trastorno por uso de cocaína y depresión: Cuando el diagnóstico clínico no es suficiente
Adicciones: Revista de socidrogalcohol, Vol. 33, Núm. 3, pp. 193-200
2020
-
Cocaine-induced changes in CX3CL1 and inflammatory signaling pathways in the hippocampus: Association with IL1β
Neuropharmacology, Vol. 162
-
Plasma tryptophan and kynurenine pathway metabolites in abstinent patients with alcohol use disorder and high prevalence of psychiatric comorbidity
Progress in Neuro-Psychopharmacology and Biological Psychiatry, Vol. 102
-
Potential association of plasma lysophosphatidic acid (LPA) species with cognitive impairment in abstinent alcohol use disorders outpatients
Scientific Reports, Vol. 10, Núm. 1
2019
-
Inflammatory mediators and dual depression: Potential biomarkers in plasma of primary and substance-induced major depression in cocaine and alcohol use disorders
PLoS ONE, Vol. 14, Núm. 3
-
Oleoylethanolamide modulates BDNF-ERK signaling and neurogenesis in the hippocampi of rats exposed to δ9-THC and ethanol binge drinking during adolescence
Frontiers in Molecular Neuroscience, Vol. 12
-
Plasma concentrations of oleoylethanolamide in a primary care sample of depressed patients are increased in those treated with selective serotonin reuptake inhibitor-type antidepressants
Neuropharmacology, Vol. 149, pp. 212-220
-
Serotonin is the main tryptophan metabolite associated with psychiatric comorbidity in abstinent cocaine-addicted patients
Scientific Reports, Vol. 9, Núm. 1
2017
-
Comorbilidad psiquiátrica y valores plasmáticos de 2-acilgliceroles en consumidores de alcohol en tratamiento ambulatorio. Análisis de las diferencias de género
Adicciones: Revista de socidrogalcohol, Vol. 29, Núm. 2, pp. 83-96
2016
-
Role of the satiety factor oleoylethanolamide in alcoholism
Addiction Biology, Vol. 21, Núm. 4, pp. 859-872